Update on Prostate Cancer Diagnosis, Prognosis, and Prediction to Response to Therapy
| dc.contributor.author | Montironi, Rodolfo | |
| dc.contributor.author | Cimadamore, Alessia | |
| dc.contributor.author | Lopez-Beltran, Antonio | |
| dc.contributor.author | Cheng, Liang | |
| dc.contributor.author | Scarpelli, Marina | |
| dc.contributor.department | Pathology and Laboratory Medicine, School of Medicine | en_US |
| dc.date.accessioned | 2022-05-04T13:53:33Z | |
| dc.date.available | 2022-05-04T13:53:33Z | |
| dc.date.issued | 2020 | |
| dc.description.abstract | The wide range of novelties reported in this Special Issue of the journal Cells on prostate cancer (PCa) diagnosis, prognosis, and prediction to response to therapy, has led us to a series of considerations related to a better understanding of the current and future role of effective molecular biomarkers in individual patients with PCa [...]. | en_US |
| dc.eprint.version | Final published version | en_US |
| dc.identifier.citation | Montironi R, Cimadamore A, Lopez-Beltran A, Cheng L, Scarpelli M. Update on Prostate Cancer Diagnosis, Prognosis, and Prediction to Response to Therapy. Cells. 2020;10(1):20. Published 2020 Dec 24. doi:10.3390/cells10010020 | en_US |
| dc.identifier.uri | https://hdl.handle.net/1805/28830 | |
| dc.language.iso | en_US | en_US |
| dc.publisher | MDPI | en_US |
| dc.relation.isversionof | 10.3390/cells10010020 | en_US |
| dc.relation.journal | Cells | en_US |
| dc.rights | Attribution 4.0 International | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
| dc.source | PMC | en_US |
| dc.subject | Tumor biomarkers | en_US |
| dc.subject | Prostatic neoplasms | en_US |
| dc.title | Update on Prostate Cancer Diagnosis, Prognosis, and Prediction to Response to Therapy | en_US |
| dc.type | Article | en_US |